Phibro Animal Health Corporation

Company type	Public
Traded as	Nasdaq:  PAHC S&P 600 Component
Industry	Animal health and nutrition
Headquarters	Teaneck, New Jersey, U.S.
Key people	Jack Bendham ( chairman) Larry Miller ( COO) [1] [2]
Revenue	US$833 million (2021) [3]
Number of employees	1,400 [4] [5]
Website	pahc.com

Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. ^{[6] [7]} The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. ^[8] The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. ^[6] It is incorporated in Delaware. ^[9]

The company was founded in 1946 as Phillip Brothers Chemicals, Inc. ^{[10] [11]}

In 1974, it acquired Koffolk, an animal nutrition company based in Israel. ^[10]

In 2000, Pfizer sold its medicated feed additives business to Phibro Animal Health ^{[12] [10]}

In 2003, the company changed its name from Phillip Brothers Chemicals to Phibro Animal Health. ^{[13] [10]}

In 2009, the company acquired Baltzell US mineral nutrition business and ABIC Laboratories, a vaccine maker from Israel. ^{[14] [10]}

In 2014, Phibro Animal Health held an initial public offering and became listed on the Nasdaq. ^{[15] [16]}

In 2018, the company established a biotech facility in Sligo, Ireland producing animal health vaccines. It became the company's first manufacturing plant in Europe. ^{[4] [5]}

• Official website

This United States corporation or company article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e